Gastric Cancer with Peritoneal Metastasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-02-18
Clinical Trial Update: Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis [Phase 2]
Phase 2 clinical trial evaluating Cadonilimab, LM-302, and S-1 with intraperitoneal paclitaxel for Claudin 18.2-positive gastric cancer with…
CLINICAL_TRIALS research · 2025-06-22
Clinical Trial Update: An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug "Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1" in Patients With Disseminated Gastric Cancer, Phase I-II [Phase 2, Phase 3]
An open prospective randomized trial evaluating intraperitoneal Prospidelong gel for gastric cancer with peritoneal dissemination; Phase 2/3…